Deadline Approaching: ATS 2022 CME/MOC
CME Certificates of credit for ATS 2022 will be awarded based on the participant attending the activity, completing and submitting an evaluation and attesting to the credits earned. A CME certificate will be available upon successful completion of all three components. You will be able to evaluate and claim CME credit until July 31, 2022.
MOC is also available. Learn more about the process and claim your points now.
View the conference accreditation and credit designation statements now. Please contact education@thoracic.org with any questions. If you have any questions about the ATS MOC portfolio, please contact us at MOC@thoracic.org.
Upcoming Events
Journal Clubs and Case Studies
Secondary Influenza Challenge Triggers Resident Memory B Cell Migration and Rapid Relocation to Boost Antibody Secretion at Infected Sites
When: 11 a.m. ET, Aug. 2, 2022
Register now.
ATS 2022 Pulmonary Circulation Abstract Awardees Presentation
When: 12 p.m. ET, Aug. 9, 2022
Register now.
PINE- Non-Cystic Fibrosis Bronchiectasis
When: 3 p.m. ET, Aug. 16, 2022
Register now.
Chronic Thromboembolic Pulmonary Hypertension and Impairment after Pulmonary Embolism: The Focus Study
When: 12 p.m. ET, Oct. 4, 2022
Register now.
Reddit Ask-Me-Anything
Join Nishant Gupta, MD, MS – associate professor, The LAM Foundation Professor for LAM Research, and director, Interstitial and Rare Lung Disease Program, Division of Pulmonary, Critical Care and Sleep Medicine at the University of Cincinnati, – for a Reddit AMA on lymphangioleiomyomatosis!
When: 2 p.m. ET, Aug. 4, 2022
Where: Reddit
Industry Innovations, “Adempas for PAH-CHD”
Join us for “Adempas for Pulmonary Arterial Hypertension associated with Congenital Heart Disease: Data from Patent-1 subgroup.”
When: 6:30 p.m. ET, Aug. 10, 2022
Register now.
Sponsored by Bayer Healthcare
International Health Committee Webinar, “The 2021 WHO Air Quality Guidelines: Perspectives from East Africa, India, and Peru”
Air pollution remains a leading modifiable risk factor for morbidity and mortality globally. Poor air quality disproportionately affects people living in resource-limited settings. This webinar will address the rationale for 2021 updated WHO air quality targets and provide the perspective from East Africa, India, and Peru on challenges and initiatives to achieve clean air targets for all.
When: 1 p.m. ET, Aug. 25, 2022
Register now.
2022 AJRCMB Junior Investigator Awards
Congratulations to Pauline Percier, PhD, and Qi Tan, PhD, the winners of the 2022 AJRCMB Junior Investigator Award! This prestigious award highlights one or more manuscripts for which the first or senior author qualifies as a Junior Investigator in each issue of American Journal of Respiratory Cell and Molecular Biology.
Assembly/Committee New and Renewal Project Application Cycle
Assembly/Committee projects are a core Society activity and provide guidance to the global community regarding topics important to ATS members.
- TBegin an ATS-only New/ Renewal project application..
- Begin a New Joint ATS/ERS application.. You will be redirected to the ERS submission site for joint ATS/ERS New Applications only.
All Project Applications must be submitted electronically on the ATS website and the ERS Website. Visit the Project Application Resource Center for instructions on how to submit your project application and navigate the project application website, as well as detailed instructions for completing the application.
Deadline: 11 p.m. ET, Aug. 2, 2022
Call for Papers: AJRCCM Asthma-Focused Special Issue
In April 2021, the American Journal of Respiratory and Critical Care Medicine published a special issue dedicated to asthma, which included articles that had an important influence on the scientific community. Several of those papers are now listed in the Highly Cited category on Web of Science.
With an impact factor of 21.4 in 2021, the AJRCCM is increasingly better positioned to help raise awareness of the current progress and continuing needs in asthma research. Therefore, we are dedicating a new, special issue to the topic of asthma in both adults and children, which will be published in February 2023.
We invite asthma researchers and scientists to submit original papers for consideration for this focused issue. We welcome submissions involving basic and translational research, epidemiological science, clinical trials, and community-based research.
Submissions must conform to the Journal’s formatting requirements and should include a cover letter mentioning the special asthma-themed issue. If you have questions, please contact Marc Bendian.
